Subscribe To This Blog

Monday, April 7, 2014

Transparency Market Research "Social Gaming Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,"the global Social Gaming market is expected to reach a value of USD 17.40 billion by 2019, growing at a CAGR of 16.1% from 2013 to 2019. Growth in the usage of internet and social networking sites has spurred the growth of the games over the internet. The other factor being the growing demand of smartphones and tablet PCs. Asia Pacific was the largest contributor in social gaming market and accounted for a share of 45% in 2012. Decline in prices of mobile devices i.e. smartphones and tablets and easy access to internet has resulted in the growth of these games.

Among different types of revenue generation methods, virtual goods helped generate 60% of the revenue followed by advertisements in 2012. Continuous rise in the internet subscribers, increase social network accounts, demand for mobile devices and free and easy access to internet are some important factors driving the demand for social gaming globally. Ban on social networking sites in regions such as the Middle East and China has limited the growth of the market. People of age group 19 - 25 years has contributed largely to the growth of social games and is expected to grow at a CAGR of 17.3 % during the forecast period from 2013 - 2019. A major reason for the growing popularity of the social games among this age group is the readily available internet services in schools, colleges or homes.

Female is the largest gender segment that held a share of around 54% in 2012 followed by male with 46 % share in 2012. Demand for games by female is primarily driven by increase in usage of internet in the homes and the rise in demand of smartphones.

In terms of geographical regions, Asia Pacific represents largest market for social gaming and is expected to reach USD 7.59 billion by 2019. Huge population in the region has boosted the demand of mobiles and smartphones which in turn has compelled the game designers to develop games of the mobile devices.

The global social gaming market was dominated by Zynga Inc. in 2012. Other important players in the global social gaming market include Playdom, Rock You, Rovio and others.

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Wednesday, April 2, 2014

The organ
preservation solutions market has been playing an important role in
increasing the number of organ transplants. Basically, an organ preservation
solution is a method that helps in preserving organs in a special place when
they are no longer inside a human body. The preservation solutions make the
organs vulnerable to the exterior environment present outside the human body.
The organs that are removed from the human body are then preserved in specific
preservative solutions for multifarious purposes such as development of drugs
and biologics and organ transplant procedures and research and development.

Now-a-days, organ
preservation solutions is widely utilized for preserving different organs such
as liver and kidney because it is highly capable of preserving a variety of
organs unlike the solutions HBS and Perfadexs.

Many interesting
medical techniques are acquired and implemented to preserve the organs in
appropriate spaces. On the basis of organ preservation techniques, the market
has been segmented into three categories namely hypothermic perfusion
preservation (HPP), static cold storage (SCS) and others (that include
normothermic preservation and oxygen insufflation techniques). However, unlike
the static cold storage (SCS) technique which does not allow any type of continuous
contact of the organ with the solution, the hypothermic perfusion preservation
(HPP) technique is a much viable technique to adapt. It is a machine perfusion
process that maintains a continuous supply to the organs required by the
solution. This helps the organs to survive properly in the duration.

Value-Drive Growth Factors of the Organ
Preservation Solutions Market

Considering the
diseases and disorders spread amongst a variety of people across the world, rising
incidences of organ failures in the patients has stirred the maximum demand for
organ preservation solutions market. The organ preservation solutions market is
primarily driven by organ failures that in turn necessitate organ transplant procedures.
Worldwide, there are a number of patients that are highly eager to get an organ
transplant done so that they live a smooth and stress-free life. Another factor
that has stimulated the demand for the organ preservation solutions market is people’s
lifestyle. Today, people are more addicted to surrounding themselves with a lifestyle
full of fast-food consumptions, alcohol, and smoking. The extreme use of such life-threatening
factors has affected the lives of thousands of people in the world.

It is also
observed that rise in geriatric population in the developed areas such as U.K
and U.S has further led to a rise in the demand for organ transplant procedures.
Such regions, health-conditions, and viability from the time of organ donation
to transplantation aspects have essentially propelled the growth of this particular
market segment.

Supplementary - Growth Contributors

The rise in per
capita healthcare expense and the advancing imbursement arrangements for the
organ transplant procedures in different nations such as U.S, U.K, and India
are auxiliary factors that have helped in the overall growth of the organ
preservation solutions market. This would enable the patients to afford the
medical procedures and reduce their medical expenses, as well as provide better
healthcare services.

In addition, the
growth of this market will also be driven with the emergence of technologically
improved products such as Lifor. Lifor is termed as a blood surrogate that will
clinically prove its effectiveness in saving and preserving human and
veterinary organs with utmost safety.

The global
market for organ preservation solutions has been predicted to grow at a CAGR
rate of 16.5% during the forecast period 2013 to 2019, with a prediction for
the market revenue to reach USD 204.9 million in the same forecast period. The
geographically active regions that help in the growth of the organ preservation
solutions market include Europe (49.96%), North America (42.23%), Asia-Pacific
(5.66%), and RoW (2.15%) for 2012 (%).

Tuesday, April 1, 2014

As the life sciences industry becomes
increasingly competitive while being pressured by regulatory mandates, business
process outsourcing (BPO) is being considered as an effective way to improve
operational performance.

The market for life sciences BPO is
comprised of two distinct entities offering their services to biotech and
pharmaceutical companies—Contract Research Organizations and Contract
Manufacturing Organizations.

But what are the factors that have
given rise to a demand for life science BPO services? The pharma industry is
constantly grappling with patent expirations, a pressure to develop low-cost
drugs, and the growing uncertainty in economic conditions. Companies in this
domain thus need to approach their core operations with singular focus. This is
where life science BPO enterprises come into the picture with their support
services. Pharma companies outsource various functions and non-core operations
to third parties with a view to streamlining their value chain and cutting
costs.

These partnerships are usually forged
in the form of long-term contracts and partnerships with CMOs and CROs. Through
these partnerships, pharma companies share costs right from drug discovery and
development to licensing to approvals with the CMOs and/or CROs.

Pharma companies are also experiencing
effective outcomes via life science BPOs; the latter leverage their experience,
trained professionals, and latest technology to the advantage of the former.

On the other hand, life-science BPOs
too have been driven by the pressure to compete and achieve profitability. They
try to accomplish this by introducing novel strategies to offer their clients a
competitive advantage. According to a market research report published by
U.S.-based market research firm Transparency Market Research, the global life
sciences BPO market is projected to record a compounded annual growth rate
(CAGR) of 21.5% between 2013 and 2019.

Experts predict a healthy growth rate
thanks to factors such as increased R&D investments by pharmaceutical companies,
a spike in the demand for generic drugs, as well as a myriad of block buster
drugs nearing the end of their patents. Other factors that have created a
favorable environment for life science BPO include stringent regulatory
mandates and government pressure to develop affordable drugs.

The
Contract Manufacturing Organizations Market

According to the market research report
published by Transparency Market Research, the CMO life science services
outsourcing currently holds the largest share in the Life Sciences BPO market.
The growth in healthcare costs has subsequently caused an increased generic
drug demand, which has in turn led to a spike in the demand for the services of
pharmaceutical outsourcing enterprises. Moreover, most CMOs have full-fledged R&D
centers that employ novel technologies to give their clients an edge.

The market for active pharmaceutical
ingredients (API) is the largest within the CMO segment. With mounting
regulatory compliance and stringent approval parameters, the outsourcing of
manufacturing activities to CMOs has received a boost.

At a time when manufacturers are
striving to stay abreast of the latest regulatory mandates and industry
breakthroughs, continually investing in facility upgrades might not be
possible. This is another factor that can be attributed to the surge in demand
for outsourcing partners as manufacturers do not possesses every required
technology or expertise in-house. In such scenarios, outsourcing not only gives
them access to the latest manufacturing technologies, but also proves to be a
cost effective strategy.

The
Contract Research Organizations (CRO) Market

Over the past decade, there has been
considerable growth in the outsourcing services offered by CROs. Many
pharmaceutical companies have been struggling to find a balance between
mounting research costs and profitability. This has led many of these firms to
turn towards CROs as a feasible option. The vendors operating in the market
currently offer a combination of various services such as research, regulatory
co-ordination services, data management, website management, medical writing,
protocol development and others.

In 2012, the largest segment within
this market was drug discovery. A report by Transparency Market Research
however projects that between 2013 and 2019, the highest growth will be seen in
the clinical data management BPO services at the rate of 17.3%.

Growth
Projections

It is estimated that the Life
Sciences BPO Market will be worth USD 596 billion worldwide by 2019,
according to the Transparency Market Research report. And, while North America
held the largest share in this market in 2012 with a worth of USD 28.4 billion,
future growth is expected to be the highest in the Asia Pacific region with an
approximate growth rate of 21.2% driven by various factors such as low cost of
labor, availability of a talent pool, a large patient population, and
comparatively favorable regulatory policies.